DK0966293T3 - Lægemiddel til fremme af sårheling indeholdende thrombocytter - Google Patents
Lægemiddel til fremme af sårheling indeholdende thrombocytterInfo
- Publication number
- DK0966293T3 DK0966293T3 DK98954056T DK98954056T DK0966293T3 DK 0966293 T3 DK0966293 T3 DK 0966293T3 DK 98954056 T DK98954056 T DK 98954056T DK 98954056 T DK98954056 T DK 98954056T DK 0966293 T3 DK0966293 T3 DK 0966293T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- wound healing
- promote wound
- healing containing
- thrombocytes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/626—Liposomes, micelles, vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0191697A AT407484B (de) | 1997-11-12 | 1997-11-12 | Arzneimittel zur förderung der wundheilung |
PCT/AT1998/000278 WO1999024044A1 (de) | 1997-11-12 | 1998-11-12 | Arzneimittel zur förderung der wundheilung enthaltend thrombozyten |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0966293T3 true DK0966293T3 (da) | 2004-06-14 |
Family
ID=3523799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98954056T DK0966293T3 (da) | 1997-11-12 | 1998-11-12 | Lægemiddel til fremme af sårheling indeholdende thrombocytter |
Country Status (10)
Country | Link |
---|---|
US (2) | US20020001624A1 (da) |
EP (1) | EP0966293B1 (da) |
JP (1) | JP2001508807A (da) |
AT (1) | AT407484B (da) |
AU (1) | AU1135499A (da) |
CA (1) | CA2277379A1 (da) |
DE (1) | DE59810715D1 (da) |
DK (1) | DK0966293T3 (da) |
ES (1) | ES2216323T3 (da) |
WO (1) | WO1999024044A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT407484B (de) | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
US7294455B2 (en) | 2003-05-16 | 2007-11-13 | The University Of North Carolina At Chapel Hill | Fixed-dried platelets cross-linked to protein |
TW200505394A (en) * | 2003-06-06 | 2005-02-16 | Asahi Medical Co | Material promoting wound healing |
DE102004018347A1 (de) * | 2004-04-06 | 2005-10-27 | Manfred Dr. Schmolz | Wundheilungsfördende Botenstoffmischung |
JPWO2006033433A1 (ja) * | 2004-09-24 | 2008-05-15 | 財団法人化学及血清療法研究所 | 創傷治癒剤 |
US20090035289A1 (en) | 2005-09-26 | 2009-02-05 | Lifecell Corporation | Dry platelet composition |
US8277837B2 (en) | 2006-01-11 | 2012-10-02 | Entegrion, Inc. | Hemostatic textile |
JP2007197353A (ja) * | 2006-01-25 | 2007-08-09 | Univ Of Tsukuba | 肝再生促進剤 |
EP2077118A1 (en) * | 2008-01-07 | 2009-07-08 | Gwo Rei Biomedical Technology Corp. | Clottable concentrate of platelet growth factors and preparation method thereof |
WO2010020247A1 (en) | 2008-08-22 | 2010-02-25 | Reapplix Aps | Multilayered blood product |
ITMI20120338A1 (it) * | 2012-03-06 | 2013-09-07 | Dr Andrea Bignotti | Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico |
US20160175364A1 (en) * | 2013-07-31 | 2016-06-23 | Rappaport Family Institute For Research In The Medical Sciences | Trophoblast derived microparticles for treating ischemic tissue and wounds |
WO2016208675A1 (ja) * | 2015-06-23 | 2016-12-29 | 株式会社Tesホールディングス | 凍結乾燥された多血小板血漿及びその使用 |
KR20180108649A (ko) | 2016-01-06 | 2018-10-04 | 레아플릭스 에이피에스 | 차후의 자가 사용을 위한 응혈 촉진 인자 |
CN111295094A (zh) | 2017-10-09 | 2020-06-16 | 泰尔茂比司特生物技术有限公司 | 冻干容器及使用冻干容器的方法 |
US11609042B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188318A (en) * | 1975-06-16 | 1980-02-12 | Edward Shanbrom | Simplified method for preparation of high yield, high purity Factor VIII concentrate |
AT350726B (de) * | 1976-08-30 | 1979-06-11 | Immuno Ag | Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma |
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
DE3165600D1 (en) | 1980-01-28 | 1984-09-27 | Baxter Travenol Lab | Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions |
US4286056A (en) * | 1980-01-28 | 1981-08-25 | Baxter Travenol Laboratories, Inc. | Method for making therapeutic enzyme compositions |
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
US4348384A (en) * | 1980-10-17 | 1982-09-07 | Dainippon Pharmaceutical Co., Ltd. | Pharmaceutical composition for oral administration containing coagulation factor VIII or IX |
EP0068047B1 (de) * | 1981-06-25 | 1986-07-23 | Serapharm GmbH & Co. KG | Angereichertes Plasmaderivat zur Unterstützung von Wundverschluss und Wundheilung |
US4442655A (en) * | 1981-06-25 | 1984-04-17 | Serapharm Michael Stroetmann | Fibrinogen-containing dry preparation, manufacture and use thereof |
ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
AT369990B (de) | 1981-07-28 | 1983-02-25 | Immuno Ag | Verfahren zur herstellung eines gewebeklebstoffes |
US5614500A (en) * | 1983-03-04 | 1997-03-25 | The Scripps Research Institute | Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
US5149787A (en) * | 1984-05-22 | 1992-09-22 | The Blood Center Research Foundation | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
US4710381A (en) * | 1984-05-22 | 1987-12-01 | The Blood Center Of Southeastern Wisconsin | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
US5185160A (en) * | 1984-06-21 | 1993-02-09 | Prp, Inc. | Platelet membrane microvesicles |
US5165938A (en) * | 1984-11-29 | 1992-11-24 | Regents Of The University Of Minnesota | Wound healing agents derived from platelets |
JPH0720873B2 (ja) * | 1984-11-29 | 1995-03-08 | キュラテック・インコ−ポレ−テッド | 創傷治癒剤 |
DE3590594T1 (da) | 1984-11-29 | 1987-01-29 | ||
US4957742A (en) | 1984-11-29 | 1990-09-18 | Regents Of The University Of Minnesota | Method for promoting hair growth |
US5178883A (en) * | 1984-11-29 | 1993-01-12 | Regents Of The University Of Minnesota | Method for promoting hair growth |
CA1294546C (en) * | 1986-04-23 | 1992-01-21 | John S. Sundsmo | Wound healing composition containing collagen |
DE3626110A1 (de) * | 1986-08-01 | 1988-02-11 | Peter Dr Terness | Immunsuppressives serum |
AT391808B (de) * | 1986-11-03 | 1990-12-10 | Immuno Ag | Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion |
GB8628108D0 (en) | 1986-11-25 | 1986-12-31 | London Biotechnology Ltd | Riboflavin-linked assay |
JPS63243032A (ja) * | 1987-03-27 | 1988-10-07 | Green Cross Corp:The | トロンビンの加熱処理方法 |
US5175087A (en) * | 1987-07-06 | 1992-12-29 | Biopool International, Inc. | Method of performing tissue plasminogen activator assay |
EP0317376B2 (fr) * | 1987-10-23 | 1996-04-03 | Centre Regional De Transfusion Sanguine De Lille | Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques |
US5213814A (en) * | 1989-04-10 | 1993-05-25 | Cryopharm Corporation | Lyophilized and reconstituted blood platelet compositions |
CA2005600A1 (en) * | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
IL95641A0 (en) | 1989-09-15 | 1991-06-30 | Curative Tech Inc | Preparation of a platelet releasate product |
IL97452A0 (en) | 1990-03-06 | 1992-06-21 | Curative Tech Inc | Compositions comprising a platelet derived wound healing factor in its preparation |
NZ237832A (en) | 1990-04-17 | 1994-05-26 | Curative Tech Inc | Coating a prosthetic surface with mammalian cells |
US6054122A (en) * | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
JP3064470B2 (ja) * | 1991-04-19 | 2000-07-12 | 杉郎 大谷 | 人工補填補綴材料 |
SE9101853D0 (sv) * | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | Improved tissue ashesive |
ATE180492T1 (de) | 1991-09-05 | 1999-06-15 | Baxter Int | Topischer fibrinogenkomplex |
EP0534178B1 (en) | 1991-09-27 | 2001-04-18 | Omrix Biopharmaceuticals S.A. | Improved tissue glue prepared by using cryoprecipitate |
US5278289A (en) * | 1991-11-12 | 1994-01-11 | Johnson Alan J | Antihemophilic factor stabilization |
WO1993013207A2 (en) * | 1991-12-31 | 1993-07-08 | Zymogenetics, Inc. | Novel human transglutaminases |
US5254536A (en) * | 1992-01-10 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Therapeutic utility of plasminogen activator inhibitor-1 to control bleeding |
EP1338648B1 (en) * | 1992-05-29 | 2005-11-30 | The University Of North Carolina At Chapel Hill | Pharmaceutically acceptable fixed-dried human blood platelets |
FR2691911B1 (fr) * | 1992-06-05 | 1994-11-25 | Delmas Olivier | Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu. |
FR2696095B1 (fr) * | 1992-09-30 | 1994-11-25 | Inoteb | Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application. |
CN1091315A (zh) * | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
DE4416166C2 (de) | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
DE4430205A1 (de) | 1994-08-26 | 1996-02-29 | Behringwerke Ag | Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung |
US5645540A (en) * | 1994-10-11 | 1997-07-08 | Stryker Corporation | Blood conservation system |
DE4438015A1 (de) * | 1994-10-25 | 1996-05-02 | Boehringer Mannheim Gmbh | Epithelzellenhaltiges Biomaterial und dessen Verwendung als Transplantat |
US5552290A (en) * | 1994-11-14 | 1996-09-03 | University Of Massachusetts Medical Center | Detection of procoagulant platelet-derived microparticles in whole blood |
US5733545A (en) * | 1995-03-03 | 1998-03-31 | Quantic Biomedical Partners | Platelet glue wound sealant |
US5736364A (en) * | 1995-12-04 | 1998-04-07 | Genentech, Inc. | Factor viia inhibitors |
US5804400A (en) * | 1996-02-05 | 1998-09-08 | Igen International, Inc. | Electrochemiluminescent assay |
US5834418A (en) * | 1996-03-20 | 1998-11-10 | Theratechnologies, Inc. | Process for the preparation of platelet growth factors extract |
JPH09286797A (ja) | 1996-04-18 | 1997-11-04 | Green Cross Corp:The | ヘパリンコファクターii及びその精製方法 |
AT403989B (de) * | 1996-09-16 | 1998-07-27 | Immuno Ag | Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels |
US6358534B1 (en) * | 1997-04-08 | 2002-03-19 | Baxter Aktiengesellschaft | Immunotolerant prothrombin complex preparation |
AT406120B (de) | 1997-08-28 | 2000-02-25 | Immuno Ag | Gewebekleber |
US5981254A (en) * | 1997-10-30 | 1999-11-09 | Haemacure Corporation | Process for producing thrombin from plasma |
AT407484B (de) | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
DE19824306A1 (de) | 1998-05-21 | 1999-11-25 | Michael Sittinger | Autologe Fibrinkleber |
DE19841698A1 (de) | 1998-09-11 | 2000-03-16 | Curative Technologies Gmbh | Wachstumsfaktor-enthaltende Zusammensetzung zur Heilung von Gewebeschäden |
AT500670A1 (de) | 1999-05-19 | 2006-02-15 | Bio & Bio Licensing Sa | Arzneimittel zur lokalen anwendung |
DE10012732A1 (de) * | 2000-03-18 | 2001-09-20 | Aventis Behring Gmbh | Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung |
IL136552A (en) | 2000-06-05 | 2005-05-17 | Omrix Biopharmaceuticals Ltd | Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration |
EP1351697B1 (de) * | 2001-01-18 | 2013-10-30 | Georg Watzek | Arzneimittel zur förderung der regeneration von gewebe |
RS20050051A (en) * | 2002-07-23 | 2007-06-04 | Bio-Products & Bio Engineering Ag., | Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity |
DK1528930T3 (da) * | 2002-07-23 | 2009-08-03 | Bio & Bio Licensing Sa | Thrombindannelsesdygtige og thrombinholdige farmaceutiske præparater af virksomt stof samt lægemidler |
AT501088A2 (de) * | 2002-12-18 | 2006-06-15 | Bio Prod & Bio Eng Ag | Stabile therapeutische proteine |
US20090275011A1 (en) * | 2008-04-30 | 2009-11-05 | Johann Eibl | Sessile stem cells |
-
1997
- 1997-11-12 AT AT0191697A patent/AT407484B/de not_active IP Right Cessation
-
1998
- 1998-11-12 WO PCT/AT1998/000278 patent/WO1999024044A1/de active IP Right Grant
- 1998-11-12 CA CA002277379A patent/CA2277379A1/en not_active Abandoned
- 1998-11-12 AU AU11354/99A patent/AU1135499A/en not_active Abandoned
- 1998-11-12 DK DK98954056T patent/DK0966293T3/da active
- 1998-11-12 EP EP98954056A patent/EP0966293B1/de not_active Expired - Lifetime
- 1998-11-12 ES ES98954056T patent/ES2216323T3/es not_active Expired - Lifetime
- 1998-11-12 DE DE59810715T patent/DE59810715D1/de not_active Expired - Lifetime
- 1998-11-12 JP JP52499499A patent/JP2001508807A/ja active Pending
-
1999
- 1999-07-12 US US09/351,985 patent/US20020001624A1/en not_active Abandoned
-
2004
- 2004-04-07 US US10/819,848 patent/US8268362B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AT407484B (de) | 2001-03-26 |
AU1135499A (en) | 1999-05-31 |
JP2001508807A (ja) | 2001-07-03 |
DE59810715D1 (de) | 2004-03-11 |
EP0966293A1 (de) | 1999-12-29 |
ATA191697A (de) | 2000-08-15 |
EP0966293B1 (de) | 2004-02-04 |
ES2216323T3 (es) | 2004-10-16 |
CA2277379A1 (en) | 1999-05-20 |
US20020001624A1 (en) | 2002-01-03 |
US8268362B2 (en) | 2012-09-18 |
US20040191231A1 (en) | 2004-09-30 |
WO1999024044A1 (de) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69825982D1 (de) | Spritze | |
DE69837906D1 (de) | Insektizides proteintoxin von xenorhabus | |
FI972292A0 (fi) | Administrering av diabetes | |
ID23874A (id) | Obat | |
DE69839157D1 (de) | Fullurene enthaltendes katherdersystem | |
DE59701787D1 (de) | Medikamenten-dosiersystem | |
ATE304351T1 (de) | Arzneizubereitungen enthaltend kannabinoide | |
NO2006014I1 (no) | Insulin glulisin | |
DE69913553D1 (de) | Konfigurierung von systemeinheiten | |
DK0966293T3 (da) | Lægemiddel til fremme af sårheling indeholdende thrombocytter | |
DE69823360D1 (de) | Feste arzneizubereitung enthaltend benzofuranderivate | |
DE69919784D1 (de) | Spritze | |
DE69808855D1 (de) | Klebstoff | |
DE69816443D1 (de) | Sicherheitsspritze | |
DK1017392T3 (da) | Lægemiddel | |
FR2774599B1 (fr) | Cataplasme | |
DE69708130D1 (de) | A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung | |
ID29294A (id) | Komposisi farmasi | |
ID25857A (id) | Komposisi farmasi | |
DE69817782D1 (de) | Gel enthaltender wundverband | |
EA199900672A1 (ru) | Гомеопатическое лекарственное средство | |
ID24413A (id) | Turunan-turunan bifenil sebagai obat-obatan | |
EA199900673A1 (ru) | Гомеопатическое лекарственное средство | |
ATA34798A (de) | Pankratisches system | |
ID22787A (id) | Nitro-benzamida berguna sebagai zat anti - arritimia |